Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study)

NCT04038047 is registered in ClinicalTrials.gov with Nicole Hamblett as lead sponsor.

NCT NCT04038047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study)
Lead sponsor
Nicole Hamblett
Phase
Observational
Overall status
Completed
Start date
October 22, 2019
Completion date
December 23, 2024
Enrollment
490 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis